BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10128747)

  • 1. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective dosage adjustment program in a geriatric population.
    Guharoy SR
    Top Hosp Pharm Manage; 1994 Apr; 14(1):67-72. PubMed ID: 10171827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-usage evaluation and the patient-care pharmacist: a synergistic combination.
    Gayman J; Tapley DJ
    Top Hosp Pharm Manage; 1991 Jul; 11(2):31-43. PubMed ID: 10128633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacy interventions: an optimum way to accomplish positive patient care outcome.
    Guharoy SR
    Top Hosp Pharm Manage; 1992 Jan; 11(4):10-5. PubMed ID: 10128683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
    Mustion AL; Sobotka J
    Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist clinical intervention program.
    Smith SR; Utterback CM; Parr DD; Waller DJ
    Top Hosp Pharm Manage; 1993 Jul; 13(2):1-15. PubMed ID: 10128810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using clinical intervention documentation.
    Harris KL
    Top Hosp Pharm Manage; 1992 Jan; 11(4):52-60. PubMed ID: 10128687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documentation and assessment of pharmacist-initiated drug therapy interventions.
    Gray DR
    Top Hosp Pharm Manage; 1992 Jan; 11(4):69-79. PubMed ID: 10128689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to assemble a patient-centered pharmacy QI program.
    Powers SM
    Top Hosp Pharm Manage; 1993 Jul; 13(2):46-54. PubMed ID: 10128814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of drug-usage evaluation with a quality assurance program.
    Carasiti ME; Lamb RE; Davio M
    Top Hosp Pharm Manage; 1991 Jul; 11(2):6-17. PubMed ID: 10128637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance: a concurrent monitoring system.
    Grabowski BS
    Top Hosp Pharm Manage; 1988 Feb; 7(4):8-13. PubMed ID: 10314270
    [No Abstract]   [Full Text] [Related]  

  • 19. A continuous quality improvement team approach to adverse drug reaction reporting.
    Flowers P; Dzierba S; Baker O
    Top Hosp Pharm Manage; 1992 Jul; 12(2):60-7. PubMed ID: 10128729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizing for drug-usage evaluation.
    Buchanan C; Sands P
    Top Hosp Pharm Manage; 1991 Apr; 11(1):16-37. PubMed ID: 10128604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.